Company profile
Annovis Bio company profile
Annovis Bio is specialty pharmaceutical company founded to develop novel treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative disorders. The company has two compounds in clinical development: Posiphen® targets early stage AD and PD and may stop or slow the progression of the disease; BNC targets late stage AD and may stabilize the decline.
Business identity
- Website
- http://annovisbio.com/
- Contact email
- [email protected]
- Phone number
- (610)727-3913
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2008-01-01
Headquarters
- Headquarters
- Morrisonville, New York, United States
- Postal code
- 19312
- Country code
- US
- Continent
- North America